Hervé Ghesquières Selected Research

BEAM regimen

12/2014	Upfront consolidation combining yttrium-90 ibritumomab tiuxetan and high-dose therapy with stem cell transplantation in poor-risk patients with diffuse large B cell lymphoma.
4/2011	(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hervé Ghesquières Research Topics

Disease

20	Lymphoma (Lymphomas) 01/2022 - 03/2009
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 09/2008
10	Hodgkin Disease (Hodgkin's Disease) 12/2020 - 11/2013
9	Neoplasms (Cancer) 01/2022 - 09/2006
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 01/2010
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 09/2015
3	B-Cell Lymphoma (Lymphoma, B Cell) 08/2021 - 04/2011
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2021
2	Multiple Myeloma 01/2020 - 10/2008
2	Pathologic Complete Response 01/2017 - 12/2014
1	Residual Neoplasm 01/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Infections 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2019
1	Inflammation (Inflammations) 10/2019
1	Disease Progression 01/2019
1	Uveitis 04/2018
1	Lymphadenopathy 10/2017
1	Necrosis 01/2017
1	Brain Neoplasms (Brain Tumor) 11/2015
1	Neuroinflammatory Diseases 11/2015
1	Pneumonia (Pneumonitis) 06/2015
1	Heart Failure 04/2015
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2015
1	Myocardial Infarction 04/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2015
1	Neutropenia 05/2013
1	Intraocular Lymphoma 11/2012
1	Lung Neoplasms (Lung Cancer) 03/2009
1	Prostatic Neoplasms (Prostate Cancer) 03/2009

Drug/Important Bio-Agent (IBA)

13	Rituximab (Mabthera)FDA Link 01/2021 - 09/2008
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2021 - 06/2019
4	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 10/2008
4	Monoclonal AntibodiesIBA 01/2020 - 11/2011
4	Vincristine (Oncovin)FDA LinkGeneric 06/2017 - 09/2008
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2015 - 09/2008
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 10/2014
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 11/2012
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 12/2014
3	Bendamustine Hydrochloride FDA Link 01/2021 - 11/2013
3	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 04/2011
3	NivolumabIBA 01/2020 - 01/2017
3	CytokinesIBA 01/2017 - 01/2010
3	Prednisone (Sone)FDA LinkGeneric 04/2015 - 09/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015 - 09/2008
2	Chimeric Antigen ReceptorsIBA 08/2021 - 11/2020
2	Brentuximab VedotinIBA 01/2019 - 06/2018
2	Interleukin-6 (Interleukin 6)IBA 04/2018 - 01/2010
2	Interleukin-10 (Interleukin 10)IBA 04/2018 - 01/2010
2	Yttrium-90IBA 12/2014 - 04/2011
2	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014 - 04/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2013 - 09/2007
1	IgKIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	obinutuzumabIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	tafasitamabIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Biological FactorsIBA 01/2021
1	tisagenlecleucelIBA 11/2020
1	axicabtagene ciloleucelIBA 11/2020
1	LipidsIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Immunomodulating AgentsIBA 01/2020
1	FluorineIBA 01/2020
1	AntigensIBA 10/2019
1	InterleukinsIBA 04/2018
1	AnthracyclinesIBA 12/2017
1	Hemoglobins (Hemoglobin)IBA 10/2017
1	Procarbazine (Matulane)FDA Link 06/2017
1	NeopterinIBA 11/2015
1	romidepsin (FK228)FDA Link 04/2015
1	Histone Deacetylase InhibitorsIBA 04/2015
1	Carmustine (FIVB)FDA Link 12/2014
1	Proteins (Proteins, Gene)FDA Link 06/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2013
1	factor AIBA 05/2013
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2012
1	Busulfan (Busulfex)FDA Link 11/2012
1	DNA (Deoxyribonucleic Acid)IBA 10/2012
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2010
1	Interleukin-13IBA 01/2010
1	Interleukin-7 (Interleukin 7)IBA 01/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2008

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 01/2022 - 09/2008
11	Therapeutics 01/2021 - 12/2014
10	Stem Cell Transplantation 01/2022 - 10/2008
3	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2019
3	Transplantation 12/2020 - 10/2008
3	Radiotherapy 01/2017 - 03/2009
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 09/2012
2	BEAM regimen 12/2014 - 04/2011
1	Immunomodulation 01/2020
1	Cell Transplantation 01/2017
1	Homologous Transplantation 01/2017
1	VAP-cyclo protocol 05/2013